Form 4 for FAST Fastenal
Accepted 2025-04-28 00:00:00 ET · period of report 2025-04-25 · accession 0000815556-25-000091 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-04-28 | 2025-04-25 | FAST | Broersma Anthony Paul | EVP-Ops | S - Sale+OE | $81.18 | -5,568 | 0 | -100% | -$452.0K |
| DM | 2025-04-28 | 2025-04-25 | FAST | Broersma Anthony Paul | EVP-Ops | M - OptEx | $26.93 | +5,568 | 4,772 | New | +$149.9K |
| DM | 2025-04-28 | 2025-04-25 | FAST | Broersma Anthony Paul | EVP-Ops | M - OptEx | $0.00 | -5,568 | 682 | -89% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-04-25 | S | D | 796 | $81.21 | 0 | D | — | — | |
| 2 | Common | Common Stock | 2025-04-25 | M | A | 796 | $23.50 | 796 | D | — | — | |
| 3 | Common | Common Stock | 2025-04-25 | S | D | 4,772 | $81.18 | 0 | D | — | — | |
| 4 | Common | Common Stock | 2025-04-25 | M | A | 4,772 | $27.50 | 4,772 | D | — | — | |
| 5 | Derivative | Employee Stock Option (Right to Buy) | 2025-04-25 | M | D | 796 | $0.00 | 0 | D | $23.50 · — to 2026-12-31 | 796 Common Stock | (F2) The option will fully vest and become exercisable over a period of eight years, with 25% vesting and becoming exercisable two years following the date of grant and the remainder vesting and becoming exercisable proportionately (12.5%) each year thereafter. |
| 6 | Derivative | Employee Stock Option (Right to Buy) | 2025-04-25 | M | D | 4,772 | $0.00 | 682 | D | $27.50 · — to 2027-12-31 | 4,772 Common Stock | (F2) The option will fully vest and become exercisable over a period of eight years, with 25% vesting and becoming exercisable two years following the date of grant and the remainder vesting and becoming exercisable proportionately (12.5%) each year thereafter. |